227 related articles for article (PubMed ID: 36928314)
1. RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axis.
Wang ME; Chen J; Lu Y; Bawcom AR; Wu J; Ou J; Asara JM; Armstrong AJ; Wang Q; Li L; Wang Y; Huang J; Chen M
J Clin Invest; 2023 May; 133(10):. PubMed ID: 36928314
[TBL] [Abstract][Full Text] [Related]
2. ACSL4-dependent ferroptosis does not represent a tumor-suppressive mechanism but ACSL4 rather promotes liver cancer progression.
Grube J; Woitok MM; Mohs A; Erschfeld S; Lynen C; Trautwein C; Otto T
Cell Death Dis; 2022 Aug; 13(8):704. PubMed ID: 35963845
[TBL] [Abstract][Full Text] [Related]
3. Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion.
Li Y; Feng D; Wang Z; Zhao Y; Sun R; Tian D; Liu D; Zhang F; Ning S; Yao J; Tian X
Cell Death Differ; 2019 Nov; 26(11):2284-2299. PubMed ID: 30737476
[TBL] [Abstract][Full Text] [Related]
4. Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy.
Sha R; Xu Y; Yuan C; Sheng X; Wu Z; Peng J; Wang Y; Lin Y; Zhou L; Xu S; Zhang J; Yin W; Lu J
EBioMedicine; 2021 Sep; 71():103560. PubMed ID: 34482070
[TBL] [Abstract][Full Text] [Related]
5. Ferroptosis: the vulnerability within a cancer monster.
Xie W; Agarwal S; Yu J
J Clin Invest; 2023 May; 133(10):. PubMed ID: 37183818
[TBL] [Abstract][Full Text] [Related]
6. Targeting DNA methylation and B7-H3 in RB1-deficient and neuroendocrine prostate cancer.
Yamada Y; Venkadakrishnan VB; Mizuno K; Bakht M; Ku SY; Garcia MM; Beltran H
Sci Transl Med; 2023 Nov; 15(722):eadf6732. PubMed ID: 37967200
[TBL] [Abstract][Full Text] [Related]
7. ACSL4: a double-edged sword target in multiple myeloma, promotes cell proliferation and sensitizes cell to ferroptosis.
Zhang J; Liu Y; Li Q; Zuo L; Zhang B; Zhao F; Fan F; Luo S; Hu Y; Sun C
Carcinogenesis; 2023 May; 44(3):242-251. PubMed ID: 36999754
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma.
Lu Y; Chan YT; Tan HY; Zhang C; Guo W; Xu Y; Sharma R; Chen ZS; Zheng YC; Wang N; Feng Y
J Exp Clin Cancer Res; 2022 Jan; 41(1):3. PubMed ID: 34980204
[TBL] [Abstract][Full Text] [Related]
9. ACSL4 contributes to ferroptosis-mediated rhabdomyolysis in exertional heat stroke.
He S; Li R; Peng Y; Wang Z; Huang J; Meng H; Min J; Wang F; Ma Q
J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1717-1730. PubMed ID: 35243801
[TBL] [Abstract][Full Text] [Related]
10. Hsp90 induces Acsl4-dependent glioma ferroptosis via dephosphorylating Ser637 at Drp1.
Miao Z; Tian W; Ye Y; Gu W; Bao Z; Xu L; Sun G; Li C; Tu Y; Chao H; Lam SM; Liu N; Ji J
Cell Death Dis; 2022 Jun; 13(6):548. PubMed ID: 35697672
[TBL] [Abstract][Full Text] [Related]
11. Polyphyllin I induces ferroptosis in castration-resistant prostate cancer cells through the ERK/DNMT1/ACSL4 axis.
Zou P; Chen Z; He Q; Zhuo Y
Prostate; 2024 Jan; 84(1):64-73. PubMed ID: 37750290
[TBL] [Abstract][Full Text] [Related]
12. Targeted Inhibition of the E3 Ligase SCF
Zhao H; Iqbal NJ; Sukrithan V; Nicholas C; Xue Y; Yu C; Locker J; Zou J; Schwartz EL; Zhu L
Cancer Res; 2020 Jun; 80(11):2355-2367. PubMed ID: 32265224
[TBL] [Abstract][Full Text] [Related]
13. Tumor suppressor miR-424-5p abrogates ferroptosis in ovarian cancer through targeting ACSL4.
Ma LL; Liang L; Zhou D; Wang SW
Neoplasma; 2021 Jan; 68(1):165-173. PubMed ID: 33038905
[TBL] [Abstract][Full Text] [Related]
14. The SOX4/miR-17-92/RB1 Axis Promotes Prostate Cancer Progression.
Liu H; Wu Z; Zhou H; Cai W; Li X; Hu J; Gao L; Feng T; Wang L; Peng X; Qi M; Liu L; Han B
Neoplasia; 2019 Aug; 21(8):765-776. PubMed ID: 31238254
[TBL] [Abstract][Full Text] [Related]
15. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition.
Doll S; Proneth B; Tyurina YY; Panzilius E; Kobayashi S; Ingold I; Irmler M; Beckers J; Aichler M; Walch A; Prokisch H; Trümbach D; Mao G; Qu F; Bayir H; Füllekrug J; Scheel CH; Wurst W; Schick JA; Kagan VE; Angeli JP; Conrad M
Nat Chem Biol; 2017 Jan; 13(1):91-98. PubMed ID: 27842070
[TBL] [Abstract][Full Text] [Related]
16. Necroptosis and ferroptosis are alternative cell death pathways that operate in acute kidney failure.
Müller T; Dewitz C; Schmitz J; Schröder AS; Bräsen JH; Stockwell BR; Murphy JM; Kunzendorf U; Krautwald S
Cell Mol Life Sci; 2017 Oct; 74(19):3631-3645. PubMed ID: 28551825
[TBL] [Abstract][Full Text] [Related]
17. ALKBH5 targets ACSL4 mRNA stability to modulate ferroptosis in hyperbilirubinemia-induced brain damage.
Zhou J; Tang J; Zhang C; Li G; Lin X; Liao S; Luo J; Yu G; Zheng F; Guo Z; Shao W; Hu H; Xu L; Wu S; Li H
Free Radic Biol Med; 2024 Aug; 220():271-287. PubMed ID: 38734267
[TBL] [Abstract][Full Text] [Related]
18. PARP Inhibition Suppresses GR-MYCN-CDK5-RB1-E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer.
Liu B; Li L; Yang G; Geng C; Luo Y; Wu W; Manyam GC; Korentzelos D; Park S; Tang Z; Wu C; Dong Z; Sigouros M; Sboner A; Beltran H; Chen Y; Corn PG; Tetzlaff MT; Troncoso P; Broom B; Thompson TC
Clin Cancer Res; 2019 Nov; 25(22):6839-6851. PubMed ID: 31439587
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia-reperfusion.
Xu Y; Li X; Cheng Y; Yang M; Wang R
FASEB J; 2020 Dec; 34(12):16262-16275. PubMed ID: 33070393
[TBL] [Abstract][Full Text] [Related]
20. PKCβII phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis.
Zhang HL; Hu BX; Li ZL; Du T; Shan JL; Ye ZP; Peng XD; Li X; Huang Y; Zhu XY; Chen YH; Feng GK; Yang D; Deng R; Zhu XF
Nat Cell Biol; 2022 Jan; 24(1):88-98. PubMed ID: 35027735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]